Chang, Sarah Esther
Feng, Allan
Meng, Wenzhao
Apostolidis, Sokratis A. http://orcid.org/0000-0002-0224-0097
Mack, Elisabeth http://orcid.org/0000-0003-4061-494X
Artandi, Maja
Barman, Linda http://orcid.org/0000-0002-2619-761X
Bennett, Kate
Chakraborty, Saborni http://orcid.org/0000-0003-0502-3757
Chang, Iris
Cheung, Peggie
Chinthrajah, Sharon
Dhingra, Shaurya
Do, Evan
Finck, Amanda
Gaano, Andrew
Geßner, Reinhard
Giannini, Heather M. http://orcid.org/0000-0002-8979-3806
Gonzalez, Joyce
Greib, Sarah
Gündisch, Margrit
Hsu, Alex Ren
Kuo, Alex http://orcid.org/0000-0003-4996-5578
Manohar, Monali
Mao, Rong
Neeli, Indira
Neubauer, Andreas
Oniyide, Oluwatosin
Powell, Abigail E.
Puri, Rajan
Renz, Harald
Schapiro, Jeffrey
Weidenbacher, Payton A.
Wittman, Richard http://orcid.org/0000-0001-5720-8329
Ahuja, Neera
Chung, Ho-Ryun
Jagannathan, Prasanna http://orcid.org/0000-0001-6305-758X
James, Judith A.
Kim, Peter S. http://orcid.org/0000-0001-6503-4541
Meyer, Nuala J. http://orcid.org/0000-0003-4597-5584
Nadeau, Kari C. http://orcid.org/0000-0002-2146-2955
Radic, Marko http://orcid.org/0000-0002-8004-282X
Robinson, William H.
Singh, Upinder
Wang, Taia T. http://orcid.org/0000-0002-3894-685X
Wherry, E. John
Skevaki, Chrysanthi http://orcid.org/0000-0001-5194-5635
Luning Prak, Eline T. http://orcid.org/0000-0002-9478-9211
Utz, Paul J. http://orcid.org/0000-0003-1181-1565
Article History
Received: 2 February 2021
Accepted: 9 August 2021
First Online: 14 September 2021
Competing interests
: C.S. received consultancy fees and research funding from Hycor Biomedical and Thermo Fisher Scientific, research funding from Mead Johnson Nutrition (MJN), and consultancy fees from Bencard Allergie. E.J.W. has consulting agreements with and/or is on the scientific advisory board for Merck, Elstar, Janssen, Related Sciences, Synthekine, and Surface Oncology. E.J.W. is a founder of Surface Oncology and Arsenal Biosciences. E.J.W. has a patent licensing agreement on the PD-1 pathway with Roche/Genentech. E.M. received consultancy fees from Roche. E.T.L.P. receives research funding from Janssen Research and Development, consultancy fees, and research funding from Roche Diagnostics, is a paid consultant for Enpicom, and serves on the scientific advisory boards of the Antibody Society, the Immune Epitope Database, and the American Autoimmune Related Diseases Association. N.J.M. reports funding to her institution from Athersys Inc, Biomarck Inc, and Quantum Leap Healthcare Collaborative, outside of the funded work. S. Chinthrajah reports grants from NIAID, CoFAR, Aimmune, DBV Technologies, Astellas, Regeneron, FARE, and is an Advisory Board member for Alladapt, Genentech, Novartis, Sanofi, and received personal fees from Nutricia. All remaining authors declare no competing interests with the research reported in this paper.